Moderna
Develops mRNA medicines carried in lipid nanoparticles, including a personalized cancer vaccine with Merck.
Interesting Engineering, 20 Aug 2026Prices by TradingView, about 15 minutes delayed. Not investment advice.
- Ticker
- MRNA · Nasdaq
- Based in
- United States
- Website
- modernatx.com ↗
How nano is it?
No filing of theirs says yet
We flag how much of a business is nanotechnology only when the company's own filings say it. Until then we describe what it makes.
What we track
Its technologies, and how far each has got
- mRNA vaccines in lipid nanoparticlesStep 5 · Everyday lifeThe COVID-19 vaccines from Pfizer-BioNTech and Moderna carry messenger RNA, instructions that get cells to make a copy of one virus protein so the immune system learns to recognize it.
- Personalized mRNA cancer vaccine (intismeran autogene)Step 3 · Real-world testingEach course is made for one patient.
On the record
Latest steps
The newest dated events on the technologies above.
- Human trial
mRNA cancer vaccine
Full results from 1,137 patients, presented at the ESMO Congress in Madrid: adding the vaccine to Keytruda cut the risk of recurrence or death by 42%.
“I’m genuinely excited about the results, and it is important to understand this is more than just a new drug.”Patrick Ott, Clinical director of the Melanoma Disease Center, Dana-Farber Cancer Institute
Healio, 23 Oct 2026 - Human trialCompany-reported
mRNA cancer vaccine
Merck and Moderna said their phase 3 trial in people whose high-risk melanoma had been removed met its main goal: with Keytruda, the vaccine lowered the risk of the cancer returning.
The ASCO Post, 21 Aug 2026 - Approval
mRNA vaccines
The FDA fully approved the Pfizer-BioNTech vaccine, now sold as Comirnaty: the first COVID-19 vaccine to get full approval. Its review covered about 20,000 people who got the vaccine and 20,000 who got a placebo.
US FDA, 23 Aug 2021 - Widely usedCompany-reported
mRNA vaccines
Pfizer and BioNTech had supplied more than one billion doses of their COVID-19 vaccine, BioNTech said.
Reuters, 9 Aug 2021 - Approval
mRNA vaccines
The FDA authorized the Pfizer-BioNTech vaccine for emergency use in people 16 and older, based on a randomized, blinded trial in thousands of people.
US FDA, 23 Aug 2021
Not investment advice. We describe what companies do and what their own filings say; we never say whether to buy or sell.